Independent Director · Oric Pharmaceuticals, Inc. (ORIC)

Steven L. Hoerter — Oric Pharmaceuticals Director Compensation (2025)

Fiscal year 2025 director compensation for Steven L. Hoerter at Oric Pharmaceuticals, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

Oric Pharmaceuticals Director Compensation Table · the one fiscal year held
In US dollars, as Oric Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$52,500$0$206,021$0$258,521

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Oric Pharmaceuticals, Inc. DEF 14A filed April 28, 2026, accession 0001193125-26-186911, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

Oric Pharmaceuticals pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit · Compensation

The rest of the Oric Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Angie You, Ph.DIndependent Director$258,521
Jacob M. Chacko, M.DDirector$0
Lori Kunkel, M.DIndependent Director$251,021
Mardi C. DierIndependent Director$266,021
Richard Heyman, Ph.DChair of the Board$306,021

The full Oric Pharmaceuticals compensation record

free company brief

This page is one director within Oric Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy